Rathbones Group’s Dynavax Technologies DVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-10,700
Closed -$150K 615
2023
Q4
$150K Hold
10,700
﹤0.01% 551
2023
Q3
$158K Buy
+10,700
New +$150K ﹤0.01% 558
2017
Q2
Sell
-10,000
Closed -$60K 320
2017
Q1
$60K Hold
10,000
﹤0.01% 313
2016
Q4
$40K Hold
10,000
﹤0.01% 308
2016
Q3
$105K Buy
+10,000
New +$144K 0.01% 295
2014
Q4
Sell
-1,200
Closed -$17K 333
2014
Q3
$17K Hold
1,200
﹤0.01% 307
2014
Q2
$19K Hold
1,200
﹤0.01% 291
2014
Q1
$22K Hold
1,200
﹤0.01% 284
2013
Q4
$24K Hold
1,200
﹤0.01% 208
2013
Q3
$14K Hold
1,200
﹤0.01% 259
2013
Q2
$13K Buy
+1,200
New +$25.3K ﹤0.01% 240

Other funds holding DVAX

Rathbones Group's DVAX Position: Q1 2024 in Review

Rathbones Group sold out of Dynavax Technologies (DVAX) in Q1 2024, closing a stake of 10,700 shares — an estimated $150K sold.

Rathbones Group first reported a position in DVAX in Q2 2013 and held it in 11 quarters. The position peaked at $158K in Q3 2023. 244 funds tracked by Wall St. Rank hold DVAX as of Q1 2024.

  • Rathbones Group reported no remaining Dynavax Technologies position as of Q1 2024 after selling out during the quarter.
  • Rathbones Group sold 10,700 Dynavax Technologies shares in Q1 2024, an estimated $150K.
  • Rathbones Group first reported a position in Dynavax Technologies in Q2 2013 and held it in 11 quarters.
  • Rathbones Group's Dynavax Technologies position peaked at $158K in Q3 2023.
  • 244 funds tracked by Wall St. Rank held Dynavax Technologies as of Q1 2024.

Based on Rathbones Group's 13F filing for Q1 2024, filed 14 May 2024.